Reported Q: Q3 2024 Rev YoY: +2.4% EPS YoY: +4.7% Move: -0.24%
ColgatePalmolive Company
CL
$93.93 -0.24%
Exchange NYSE Sector Consumer Defensive Industry Household Personal Products
Q3 2024
Published: Oct 25, 2024

Company Status Snapshot

Fast view of the latest quarter outcome for CL

Reported

Report Date

Oct 25, 2024

Quarter Q3 2024

Revenue

5.03B

YoY: +2.4%

EPS

0.90

YoY: +4.7%

Market Move

-0.24%

Previous quarter: Q2 2024

Follow this company to get upcoming quarter alerts automatically.

Earnings Highlights

  • Revenue of $5.03B up 2.4% year-over-year
  • EPS of $0.90 increased by 4.7% from previous year
  • Gross margin of 61.1%
  • Net income of 737.00M
  • ""volume growth in all six divisions for the second straight quarter with 3% growth in developed markets and 4.6% growth in emerging markets."" - Noel Wallace
CL
Company CL

Executive Summary

Colgate-Palmolive reported a solid Q3 2024 with revenue of $5.033 billion, up 2.4% year over year and ongoing organic growth driven by volume share gains across all six divisions. Management emphasized a strategy of premium and core innovation, higher advertising investment, and geographic breadth to sustain growth even as category growth decelerates in some markets. Gross margin expanded meaningfully (gross margin 61.1% versus prior periods), supporting operating margin of 21.2% and a net margin of 14.6%, while management continued to reinvest margin gains into advertising and capabilities to fuel long‑term brand health and household penetration. Cash flow remained a strength, with operating cash flow of $1.167 billion and free cash flow of about $1.033 billion, underpinning a healthy balance sheet despite a leveraged position.

Key Performance Indicators

Revenue
Increasing
5.03B
QoQ: -0.49% | YoY: 2.40%
Gross Profit
Increasing
3.07B
61.08% margin
QoQ: 0.16% | YoY: 6.85%
Operating Income
Increasing
1.07B
QoQ: -8.03% | YoY: 3.50%
Net Income
Increasing
737.00M
QoQ: 0.82% | YoY: 4.10%
EPS
Increasing
0.90
QoQ: 1.12% | YoY: 4.65%

Revenue Trend

Margin Analysis

Historical Earnings Comparison

PeriodRevenue ($M)EPS ($)YoY GrowthReport
Q1 2025 4,911.00 0.85 -3.0% View
Q4 2024 4,945.00 0.90 -0.1% View
Q3 2024 5,033.00 0.90 +2.4% View
Q2 2024 5,058.00 0.89 +4.9% View
Q1 2024 5,065.00 0.83 +6.2% View